OSAGY yields 1.64% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, OSAGY + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OSAGY + MRK for your $10,000?
OSRAM Licht AG provides various lighting products and solutions worldwide. The company operates through three segments: Opto Semiconductors, Automotive, and Digital. It manufactures light-emitting diodes (LEDs) that are used in general lighting, automotive, consumer, and industrial applications; and infrared, laser, and optical sensors for the automotive, smartphone, wearable, general lighting, industrial lighting, and projection sectors, as well as lightings for plants. The company also develops and produces lamps and lighting systems for stages, cinemas, and studios; LED-based plant cultivation systems; lighting solutions for industrial and medical applications, such as high-intensity UV lamps and LED illumination for clothing; and automotive systems based on LED and laser technology, and other customer-specific system solutions. In addition, it develops, produces, and markets LED light engines and light management systems, as well as electronic ballasts, LED drivers, and LED modules. Further, the company is involved in the provision of products in the areas of architectural interior and exterior lighting, as well as professional interior lighting solutions. It provides its products under the OSRAM, Vixar, SYLVANIA, Traxon, e:cue, Digital Lumens, Fluence, Clay Paky, ADB Stagelight, OSRAM CONTINENTAL, LED Engin, and b,a,g, brands. The company was formerly known as Kyros A AG and changed its name to OSRAM Licht AG in November 2012. The company was founded in 1906 and is headquartered in Munich, Germany. OSRAM Licht AG operates as a subsidiary of ams AG.
Full OSAGY Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.